TORNADO

Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway

Scientific and technological services, namely, pharmaceutical research and design services relating thereto in the nature of pharmaceutical development; pharmaceutical development services; scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; pharmaceutical testing, pre-clinical research, and clinical research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; medical research; provision of information and consultancy relating to medical and scientific research in the fields of clinical trials, oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, and the mTOR pathway